202 related articles for article (PubMed ID: 10624349)
1. CT guided interstitial high dose rate brachytherapy for recurrent malignant gliomas.
Kolotas C; Birn G; Baltas D; Rogge B; Ulrich P; Zamboglou N
Br J Radiol; 1999 Aug; 72(860):805-8. PubMed ID: 10624349
[TBL] [Abstract][Full Text] [Related]
2. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
[TBL] [Abstract][Full Text] [Related]
3. Interstitial iridium-192 implantation for malignant brain tumours. Part II: Clinical experience.
Chun M; McKeough P; Wu A; Kasdon D; Heros D; Chang H
Br J Radiol; 1989 Feb; 62(734):158-62. PubMed ID: 2538197
[TBL] [Abstract][Full Text] [Related]
4. Interstitial brachytherapy using iridium-192 for malignant brain tumors: clinical results.
Liu Z; Yu X; Guo Y; Li S; Cui Y; Yu X; Yuan Z; Kang J
Chin Med J (Engl); 1999 Feb; 112(2):139-42. PubMed ID: 11593580
[TBL] [Abstract][Full Text] [Related]
5. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
[TBL] [Abstract][Full Text] [Related]
6. Treatment options in high-grade brain tumors: brain brachytherapy.
Chin HW; Lefkowitz DM; Eisenberg RL
Radiographics; 1992 Jul; 12(4):721-9. PubMed ID: 1321981
[TBL] [Abstract][Full Text] [Related]
7. Brachytherapy of malignant gliomas.
Skultety FM; Kumar PP; Good RR; Leibrock LG
Nebr Med J; 1988 Jun; 73(6):166-8. PubMed ID: 2839782
[No Abstract] [Full Text] [Related]
8. [Iridium 192 brachytherapy of supra-tentorial high grade glioma recurring in irradiated areas: technique and preliminary results of the Pitié-Salpêtrière hospital group].
Boisserie G; Cornu P; Dormont D; Sahel M; Hardiman C; Tep B; Mandin AM; Barret C; Faillot T; Delattre JY; Monjour A; Poisson M; Marsault C; Philippon J; Simon JM; Baillet F; Mazeron JJ
Bull Cancer Radiother; 1996; 83(3):144-52. PubMed ID: 8977564
[TBL] [Abstract][Full Text] [Related]
9. Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas.
Fabrini MG; Perrone F; De Franco L; Pasqualetti F; Grespi S; Vannozzi R; Cionini L
Strahlenther Onkol; 2009 Aug; 185(8):524-9. PubMed ID: 19652936
[TBL] [Abstract][Full Text] [Related]
10. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
Grills IS; Martinez AA; Hollander M; Huang R; Goldman K; Chen PY; Gustafson GS
J Urol; 2004 Mar; 171(3):1098-104. PubMed ID: 14767279
[TBL] [Abstract][Full Text] [Related]
11. [Interstitial brachytherapy for malignant gliomas using the Brown-Roberts-Wells (BRW) stereotactic system].
Matsumoto K; Tomita S; Sakurai M; Maeshiro T; Matsuhisa T; Tsuno K; Kunishio K; Mishima N; Furuta T; Nishimoto A
No Shinkei Geka; 1990 Sep; 18(9):829-36. PubMed ID: 2172851
[TBL] [Abstract][Full Text] [Related]
12. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
[TBL] [Abstract][Full Text] [Related]
13. Interstitial irradiation versus interstitial thermoradiotherapy for supratentorial malignant gliomas: a comparative survival analysis.
Stea B; Rossman K; Kittelson J; Shetter A; Hamilton A; Cassady JR
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):591-600. PubMed ID: 7928490
[TBL] [Abstract][Full Text] [Related]
14. [CT-guided manual afterloading with 198-gold seeds in intracerebral tumors].
Glaser FH; Basche S; Gaerisch F; Haberland N; Keiner P; Keinert K; Pothe H; Steube D
Rev Med Chir Soc Med Nat Iasi; 1991; 95(3-4):275-8. PubMed ID: 1823446
[TBL] [Abstract][Full Text] [Related]
15. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E
Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470
[TBL] [Abstract][Full Text] [Related]
16. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
[TBL] [Abstract][Full Text] [Related]
17. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
18. A phase I trial of neutron brachytherapy for the treatment of malignant gliomas.
Patchell RA; Yaes RJ; Beach L; Kryscio RJ; Davis DG; Tibbs PA; Young B
Br J Radiol; 1997 Nov; 70(839):1162-8. PubMed ID: 9536908
[TBL] [Abstract][Full Text] [Related]
19. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
20. Interstitial irradiation for CNS lesions.
Teixeira MJ; Lepski G; Correia C; Aguiar PH
Stereotact Funct Neurosurg; 2003; 81(1-4):24-9. PubMed ID: 14742960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
